More Than A Magazine, A Movement
The U.S. ranks as the 19th most dangerous country for women, 11th in maternal mortality, 30th in closing the gender pay gap, 75th in women’s political representation, and painfully lacks paid family leave and equal access to health care. But Ms. has always understood: Feminist movements around the world hold answers to some of the U.S.’s most intractable problems. Ms. Global is taking note of feminists worldwide.
This week: news from Hong Kong, Mexico, Denmark and more.
Ms. has always understood: Feminist movements around the world hold answers to some of the U.S.’s most intractable problems. Ms. Global is taking note of feminists worldwide.
This week: news from Gaza, Japan, Sudan, Canada and more.
Opill, the first over-the-counter birth control pill, is set to hit drugstores, grocery stores and online shelves in the first quarter of 2024. But the real challenge lies ahead: Will it be affordable and truly accessible to all?
Opill is a progestin-only oral contraceptive pill, boasting a success rate as high as 98 percent in preventing pregnancies. The U.S. Food and Drug Administration hailed the approval of Opill as a breakthrough that could “reduce barriers to access” for those seeking contraception.
However, the promise of accessibility hinges on the crucial factor of affordability.
With the 2024 presidential election on the horizon, the U.S. is facing a pivotal moment in its ongoing struggle for reproductive rights. The escalating conflict, now at the forefront of national debate, reveals a profound and disproportionate impact on Black, brown, Indigenous, Latinx and other marginalized communities.
This was the focus of “Landscape for Abortion Access in 2024,” a briefing hosted by Conway Strategic held ahead of what would have been the 51st anniversary of Roe v. Wade on Jan. 14. The event brought together experts and advocates to discuss the challenges and realities of abortion access in the current political climate.
